Results 131 to 140 of about 62,186 (290)
Abstract Background Accurate population prevalence estimates of eating difficulties in children and young people provide essential information for the design and implementation of prevention efforts. We aimed to (I) explore the proportion of students reporting eating difficulties in a large English secondary school sample, (II) analyse factors ...
Clara Faria +5 more
wiley +1 more source
Publicity and Bulimia Nervosa [PDF]
Fairburn, C, Cooper, P, O'Connor, M
openaire +3 more sources
Abstract Background Understanding symptom patterns of emerging psychopathology is essential for early detection and intervention. Network analysis offers a promising approach by conceptualizing emerging psychopathology as dynamic interactions between symptoms over time.
Xenia A. Häfeli +3 more
wiley +1 more source
Bulimia nervosa: farmaci efficaci
Gli SSRI, in particolare la fluoxetina, sono i farmaci di prima linea per la bulimia nervosa. Dosi più elevate (60-80 mg di fluoxetina) risultano più efficaci rispetto a dosi inferiori.
Scott Crow
core +1 more source
Nail Disorders in Systemic Conditions
ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley +1 more source
Abstract Objective Our systematic review and meta‐analysis aimed to investigate how Cognitive‐Behavioural Therapy (CBT) performs against control conditions, such as waiting‐list, self‐help interventions, psychological and pill placebos and treatment as usual (TAU) in Bulimia Nervosa (BN) and Binge Eating Disorder (BED).
Angeliki L. Sioziou +10 more
wiley +1 more source
Predicting symptoms of bulimia nervosa and body dysmorphic disorder based on childhood trauma: The mediating role of psychological flexibility and self-compassion [PDF]
Introduction: Adolescents with childhood trauma are at high risk for developing psychiatric disorders such as bulimia nervosa and body dysmorphic disorder.
Motahhareh Kargar Shooroki +2 more
doaj
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
INTRODUCTION: Up to 1% of young women may have bulimia nervosa, characterised by an intense preoccupation with body weight, uncontrolled binge-eating episodes, and use of extreme measures to counteract the feared effects of overeating.
Hay, Phillipa (R12066) +1 more
core
Gut microbiota as a novel therapeutic target for eating disorders and obesity
The graphical abstract highlights the bidirectional interaction between the gut microbiota and central homeostatic and hedonic mechanisms regulating food intake, which contributes to overweight and obesity. It also illustrates emerging microbiota‐based biomarkers and therapeutic strategies (including prebiotics, probiotics, postbiotics, synbiotics and ...
Solveiga Samulėnaitė +5 more
wiley +1 more source

